News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Collaboration With Zydus Cadila Expires - Karo Bio AB Continues to Develop Safer Glucocorticoids


4/2/2012 10:47:38 AM

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Karo Bio AB (publ)(STO:KARO) and the Indian pharmaceutical company Zydus Cadila have decided not to further extend their joint glucocorticoid receptor research and development program. Karo Bio focuses its continued development towards a previously not described mechanism of glucocorticoid regulation.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES